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IN T R O D U C T IO N

General Background and Purpose

Epidemologicul studies have indicated an increased incidence
of duodenal ulcer in cigarette smokers (Barnett, 1927; Smoking find
Health, 1964; Monson, 1970). This association between smoking and ul
cer is generally not considered to he a cause and effect relationship
due primarily to the lack of laboratory evidence for a mechanism con
necting any component of cigarette smoke (e.g. tar, nicotine) with du
odenal ulcer formation.
Nicotine has been shown to increase the ulcerogenicity of cer
tain gastric secretogogues (pentagastrin + carbachol) for the duoden
um in the rat.

Robert et al.(1971) have recently demonstrated that

when these secretogogues were infused in small doses over a twentyfour hour period, duodenal ulcers were produced in one-third of the
animals.

When nicotine sulfate was added to the infusion, the ulcer

incidence, severity and number per duodenum were increased.

This

effect of nicotine was dose dependent. Using cats, Konturek et al.
(l97l) observed a similar potentiating effect of nicotine on duoden
al ulcers produced by the continuous infusion of pentagastrin.

Toon

et al.(l95l) have also shown that the chronic inhalation of cigarette
smoke in dogs abets the ulcerogenic effect of histamine in beeswax,
an effect they believed to be caused by nicotine. Chronic inhalation
of denicotinized cigarettes caused no increase in duodenal ulcers.
This response was also dose related since an increase in the number
of cigarettes smoked increased the incidence of peptic ulcers.
1
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Konturek et al« (1972) have shown that the intravenous infusion
of nicotine in dogs, in doses corresponding to amounts absorbed dur
ing smoking, decreased secretin-stimulated pancreatic secretion of
fluid and bicarbonate.

Since gastric acid in the lumen of the duoden

um is normally neutralized by pancreatic juice and to a lesser extent
by bile, it was suggested that nicotine might exert this pro-ulcer ef
fect by preventing such neutralization.
Secretin also acts to prevent an abnormal acid milieu in the duo
denum by inhibiting gastric secretion of acid (Greenlee et al..1957).
The possibility also exists that nicotine could interfere with the in
hibitory effect of secretin on the stomach.
mined.

This has not been deter

If the situation exists whereby nicotine also blocks the ef

fect of secretin on the stomach, the result would be a greater acid
milieu in the lumen of the duodenum and this condition could also
promote ulcer formation.

The effect of nicotine on pancreatic and

biliary secretion has been studied in the dog (Konturek et al, 197l).
They have shown that nicotine decreases both secretin-stimulated pan
creatic secretion and spontaneous biliary secretion in the dog.
Furthermore, Konturek jet al.(l97l) have examined the effect of nico
tine on gastric secretion in cats and dogs and have shown that nico
tine has no effect on gastric secretion stimulated with pentagastrin.
The effect of nicotine on basal and pentagastrin-stimulated gastric
secretion has been previously studied by Thompson using pylorusligated rats (Thompson and Bruckner, 1969) and rats prepared with
chronic gastric fistulas (Thompson, 1970. Thompson, jrt al, 1970).

It

was not the purpose of our investigation to examine completely, the
effects of nicotine on gastric secretion.

However, it was the purpose
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of tliis investigation to learn more about the pro-ulcer effect of
nicotine by studying the influence of nicotine on the effect of exog
enous secretin on gastric secretion.

This was done in rats equipped

with chronic gastric fistulas and in a dog prepared with a denervated
fundic pouch (ileidenhain) and a gastric fistula.

In order to estab

lish a gastric secretory response, pentagastrin was infused subcutan
eous ly in the rats and intravenously in the dog.

The effect of an

infusion of secretin on pentagastrin-stimulated gastric secretion was
then established.

Subsequently, nicotine sulfate was infused in com

bination with secretin to study the influence of nicotine on the effect
of secretin on gastric secretion.

Literature Review

As early as 1897i Dolinski and his associates found that when
hydrochloric and other acids were allowed to enter the intestine, pan
creatic juice began to flow.

However, it was not until 1902 when

Bayliss and Starling observed an increase in pancreatic secretion when
acid was applied to a denervated loop of the jejunum that a hormonal
theory for external pancreatic secretion was proposed.

These obser

vations of Bayliss and Starling led to the discovery of secretin.
Secretin was then defined as a hormone which was released by the
upper intestinal mucosa when the latter was exposed to certain chemical
substances and which stimulated the secretion of pancreatic juice.
I'rom this discovery the theory of a humoral mechanism evolved and was
used to designate a process which changes the fuction of an organ by
the carrying to that organ of some blood-borne substance.

The actual
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proof for such a mechanism did not come about until 1926 when Ivy
and Farrell showed that a transplanted portion of the pancreas, com
pletely separated from its original blood and nerve supply, was stim
ulated to secrete after the ingestion of a meal.

They concluded that

this was positive proof for the existence of a humoral mechanism for
external pancreatic secretion.

Much research has been performed in the

ensuing seventy-one years following the discovery of secretin in an ef
fort to discover what it is and where and how it functions.

Detailed

reviews of many of these earlier investigations have been written by
Still (l93l)» Babkin (1950) and Grossman (1950; 1958).
Early attempts to isolate secretin were unsuccessful because
appropriate procedures for the purification of polypeptides were not
available.

Finally in 1966, with the advance of new methods, Mutt and

Jorpes were able to describe the molecular structure of the hormone.
Secretin was shown to be a polypeptide of twenty-seven amino acid res
idues comprising eleven different amino acids.

It is also known that

secretin is strongly basic because of its particular amino acid com
position.

This alkalinity may in part be the reason that the hormone

is released when acid enters the duodenum (Hubei, 1972).

Secretin

was also synthesized in 1966 by Bodansky and co-workers and its poten
cy was found to be equal to that of

natural secretin.

More recent investigations have confirmed that the presence of acid in the duodenum acts as the stimulus for the release of secretin
from the duodenal mucosa. Thomas and Crider (l940) have shown that pan
creatic bicarbonate secretion begins only when the duodenal contents
are more acid than pH 5. The importance of this acid stimulus has been
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veil established by Hallenbeck (.1951 ) and Grossman (1967) vho have
observed a two-fold increase in the pancreatic secretory rate upon
diversion of the alkaline pancreatic juice from the duodenum.

The

exact mechanism by which acid acts as a stimulus for the release of
secretin is unknown.

However, it has been suggested that acid acts in

conjugation with other hormonal and neural stimuli which may also play
a part in the release of secretin (ilubel, 1972).
Upon release from the duodenal mucosa secretin has been shown to
affect a variety of organs.

Secretin has been reported to increase

the secretory rate of the Brunner's glands of the duodenum in the dog
(Cooke and Grossman, 1966; Stening and Grossman, 1969)0

Cohen (l97l)

has shown that secretin also exhibits an effect on the human esophagus.
Either an intravenous injection or infusion of secretin inhibited a
gastrin-induced rise in pressure at the lower esophageal

sphincter.

Secretin has been shown to affect the liver by causing a moderate
stimulation of bile production in a number of animal species but causes
only a slight increase in bile secretion in rats.

A review of this

work on bile secretion has been presented by Ilubel (1972).

Secretin

augments the strength of gall bladder contraction elicited by cholecystokinin (Stening and Grossman, 1969) and affects the kidney by increas
ing renal excretion of water, sodium and potassium (Barbezat et al..
197l)»

Secretin has also been shown to increase cardiac output in cats

and dogs (ltoss, 1970) and to stimulate lipolysis in. a number of animal
species (Rudman, 1969).
Much of the current research concerns the effect of secretin on
the pancreas (endocrine and exocrine) and the stomach.

Secretin has
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"been shown to affect the exocrine pancreas by increasing salt and
water secretion.

Increased secretion is usually within thirty seconds

post-injection and the duration of the response is increased with the
dose of secretin used, up to a maximum of 2.5 U/kg (llickson, 1970).
Ilickson has also shown that the sensitivity of the pancreas to secre
tin depends on the species in which the hormone was tested.

Using

secretin extracts he observed that the threshold dose in dogs was much
higher than in pigs, although doses necessary to achieve maximal rates
of secretion were similar.

Gregory (1962) reported that maximal bi

carbonate output in dogs was obtained with 1-2 U/kg of secretin where
as in cats 0.8 "U/kg caused maximal bicarbonate production when inject
ed intravenously.

A reduction in volume and bicarbonate output was

observed in dogs and cats with supramaximal doses of secretin (Henrickson, 1968; Konturek, 1969) and was believed to be caused by side
effects such as restlessness and retching which were caused by the sec
retin preparations.

Human studies by Konturek (1970) indicated max

imal pancreatic secretion of bicarbonate with only 0.9 U/lcg by single
intravenous injection or by constant infusion.
Large doses of secretin have also been shown to affect the endo
crine pancreas by liberating insulin in fasting animals.

Unger et. al.

(1967) have shown that in dogs, after a single intravenous injection
of secretin, in doses which cause maximal pancreatic secretion, the
concentration of insulin in the portal venous blood increased and
then fell to normal within ten minutes.

Similar increases in insulin

concentrations of the peripheral blood have been reported in healthy
and diabetic humans following intravenous administration of secretin
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7
(Chisholm e_t al., 1969),

The infusion of low doses of secretin have

been shown to potentiate the effect of glucose on increasing pancre
atic insulin secretion (Dupre, 1969).
The discovery of the inhibition of gastric acid secretion by
secretin was first made by Greenlee and his associates (1957).

They

suggested that secretin was involved in the duodenal inhibition of
gastric secretion.

This early study revealed that intravenous injec

tions of secretin in dogs inhibited the response of a denervated
fundic pouch (Heidenhain) to food and to antral pouch stimulation (i.e.
endogenous gastrin) but not to histamine.

Jordan and Peterson (1962)

also noticed a marked inhibition by secretin of the Heidenhain pouch
response to feeding.

Single intravenous injections of secretin have

also been shown to inhibit Heidenhain pouch secretion stimulated by the
continuous infusion of a gastrin extract (Gillespie and Grossman, 1964).
Wormsley and Grossman (1964) have observed that a single intravenous
administration of secretin inhibited gastrin-stimulated acid secretion
from the Heidenhain pouch (denervated) as well as from the gastric fis
tula (i.e. the remaining portion of the main stomach which is innerva
ted).

Since these studies it has been well established that secretin

inhibits gastric acid secretion when the stimulus is gastrin or penta
gastrin (Nakajima et al., 1969; Johnson and Grossman, 1968; Johnson
and Grossman, 197l).

Histamine-induced gastric acid secretion in

vagally denervated pouches in dogs is either unaffected by secretin
(Johnson and Grossman, 1968) or is inhibited only when there is a submaximal gastric secretory response (Nakajima et al., 1969).

Gastric

secretion stimulated by gastrin or by pentagastrin has also been shown
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to be inhibited by either intravenous injections or infusions of
secretin in the rat (Tumpson and Johnson, 1969; Johannson at al.,
1972), cat (Stening _et al.. 1969) and to a lesser extent in man
(Brooks and Grossman, 1970)•
Pepsin secretion rises following secretin administration in a
number of animal species.

Secretin (75 U/kg), either injected or in

fused, increased the concentration of pepsin from both Heidenhain
pouches (denervated) and Pavlov pouches (innervated) in rats stim
ulated with gastrin (Johannson et al., 1972).

However, total pepsin

output was observed to rise only in the response of the Heidenhain
pouch.

Magee and Nakajima (1968) observed an eight-fold increase in

pepsin output from the Heidenhain pouch of dogs when secretin
(3 U/min) was infused intravenously.

This increase in pepsin se

cretion was present in dogs stimulated with either histamine or gas
trin pentapeptide.

Stening at al. (1969) have confirmed this pepsi-

gogue effect of secretin in dogs and have also observed a similar
stimulatory effect on pepsin secretion in cats.

In these experi

ments, either an intravenous injection of secretin or the closure of
the gastric fistula (causing release of endogenous secretin) increased
the pepsin output from the Heidenhain pouch of cats.

Injections of

1-4 U/kg of secretin in humans causes pepsin secretion to

rise to

levels almost three times that of the basal rate (Brooks et al..
1969).

Berstad and Peterson (1970) have shown that in man, the com

bination of secretin and pentagastrin caused an increase in pepsin
output higher than can be obtained as a maximal response to either
agent alone.
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Nicotine has recently been shown to potentiate duodenal ulcers
in the rat produced by either the subcutaneous infusion of certain
secretogogues (pentagastrin + carbachol) or by the perfusion of
0.12 N hydrochloric acid through the esophagus (Robert, 197-5
Robert et al.t 197l).

The intravenous infusion of nicotine

(100 ug/kg/lir) also increased the ulcer severity and incidence in
Celts infused continuously for thirty-six hours with pentagastrin.
This dose of nicotine potentiated the ulcerogenic effect of penta
gastrin but was a dose which by itself had no effect on gastric acid
secretion (Konturek et al., 197l).

Chronic inhalation of cigarette

smoke increases the ulcerogenicity for the duodenum of histamine in
beeswax in dogs (Toon et al., 195l).

This effect was attributed to

nicotine since chronic inhalation of denicotinized cigarettes pro
duced no increase in duodenal ulcers.

Studies on the effect of to

bacco smoking on the etiology of duodenal ulcers in man are unclear.
However, cigarette smokers are known to have a higher incidence of
duodenal ulcer than non-smokers (Smoking and Health, 196k).

Tobac

co smoking has also been implicated as a contributory factor in the
reduced healing of peptic ulcers in man (Doll et al., .1958; Doll,
196k).
Few studies have been conducted which examine the effect of
nicotine on gastric secretion.
contradictory.

Those which have been published are

In gastric fistula rats stimulated with gastrin

pentapeptide, the infusion of nicotine (100 ug/kg/lir) has been shown
to have no effect on gastric acid secretion (Thompson, 1970). On the
other hand, Thompson and Bruckner (1969) have also observed that
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nicotine depressed gastric acid and pepsin secretion in pylorusligated rats.

They have shown that the subcutaneous infusion of

nicotine hydrogen tartrate (60-80 ug/kg/lir) in pylorus-ligated rats,
caused maximal depression of basal gastric secretion.

Thompson

et al. (1970) have also shown that subcutaneous injections of var
ious doses of nicotine (50-200 ug/kg) depressed acid and pepsin
secretion from pylorus-ligated raij stimulated with gastrin pentapeptide.

In gastric fistula rats stimulated with histamine, the

subcutaneous infusion of nicotine (100 ug/kg/lir) also decreased acid
and pepsin output (Thompson, 1970).

Chronic administration of nic

otine has been shown to stimulate gastric secretion of acid and pep
sin.

Chronic subcutaneous injections of nicotine (500 ug/kg/day for

15 days) resulted in an increase in gastric juice volume, acid output
and pepsin output in pylorus-ligated rats (Thompson et al., 1970).
Chronic oral ingestion of nicotine for fifteen days has also been re
ported to increase the output of acid and pepsin from the rat stomach
after ligation of the pylorus (Thompson et al., 1970).

Thompson

(1972) has also studied the effects of chronically administered nic
otine (2 mg base/lcg/day) on gastric secretion in pylorus-ligated rats
with hypothalamic lesions.

Chronic injections of nicotine increased

gastric juice volume, acid output and pepsin output in control rats.
The destruction of the anterior hypothalamus abolished this effect of
nicotine.

Thompson concluded that this stimulatory effect of nico

tine on gastric secretion in the rat was mediated through the hypo
thalamic area.
Konturek et al. (l97l) have studied the effect of nicotine
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infusion (100 ug/kg/hr) on pancreatic, biliary and gastric secretion
in the dog.

Wien nicotine was infused intravenously in dogs equipped

with a biliary cannula, the volume and bicarbonate output of unstim
ulated hepatic bile was decreased by 50 percent.

A similar dose

dependent inhibition of secretin-stimulated secretion of fluid and bi
carbonate from the pancreas was also observed.

Secretin-stimulated

pancreatic secretion was depressed 62 percent at a dose of 100 ug/kg/hr
of nicotine.
secretion.

This same dose of nicotine had no effect on gastric
The continuous infusion of nicotine at doses of 100-200

ug/kg/hr has been shown to have no effect on gastric secretion from
fistula cats stimulated with pentagastrin (Konturek et al..» 1971)•
Higher doses of nicotine (400 ug/kg/hr) did decrease gastric secretion
but was accompanied by such side effects as retching and restlessness.
These same investigators (1972) have studied the effect of nicotine
on the pancreatic action of exogenous secretin as well as the action
and release of endogenous secretin.

Intravenous infusion of nicotine

(100 ug/kg/hr) inhibited pancreatic secretion stimulated by exogen
ous secretin (0.57-3 U/kg/lir) and by endogenously released secretin
elicited by the intraduodenal infusion of hydrochloric acid.

Nico

tine depressed by 50 percent, pancreatic secretion stimulated by
1.5 U/kg/hr (ED^q) of secretin.

The intraduodenal application of

nicotine decreased pancreatic secretion stimulated by

endogenously

released secretin but not to the intravenous infusion of the hormone.
Prom these studies in the dog, Konturek eib al. have proposed a pos
sible mechanism for the pro-ulcer effect of nicotine observed by
himself (l97l)» Robert (1972; Robert et al., 197l) and Toon (l95l).
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It was suggested that nicotine favors ulcer formation by block
ing the stimulatory effect of secretin on pancreatic secretion of
fluid and bicarbonate.

This alkaline pancreatic secretion is crit

ical to neutralization of gastric acid flowing over the duodenum.
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MATERIALS AND METHODS

In tliis investigation experiments were performed in chronic fis
tula rats and in a dog prepared with a denervated fundic pouch
(Heidenhain) and a gastric fistula.

The rat fistula preparation

allowed all of the juice from the stomach to be collected externally.
In the dog, gastric juice was collected from the Heidenhain pouch.

In

each experiment it was necessary that the gastric fistula remain open.
This prevented gastric juice from the main stomach from passing over
the duodenum and thus releasing unknown amounts of endogenous intes
tinal inhibitors, such as secretin, of gastric secretion.
Pentagastrin, infused subcutaneously in rats and intravenously in
the dog, was used to stimulate gastric secretion.

During the studies

in both species, the gastric secretory response to pentagastrin was
first established.

The following conditions were then examined.

First, it was necessary to establish the effects of an infusion of
secretin upon pentagastrin-stimulated gastric secretion.

It was also

necessary to establish that the doses of nicotine employed during these
studies had no effect when infused against a background of pentagas
trin-stimulated gastric secretion.

This was essential since any in

hibitory effect of nicotine infused alone might mask the effect of
secretin.

Finally, secretin was infused in combination with nicotine

to determine if nicotine would alter the effect of secretin on gastric
secretion.

In the experiments in both species, nicotine was infused

one hour prior to the administration of secretin.

This allowed a pre

treatment with nicotine and insured adequate absorption.

Specific

13
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details concerning the preparation of the animals and the design of
the experiments are given below.

Pharmacological Agents

Pentagastrin (an analogue of the C-terminal five amino acids of
gastrin, N-5-butyloxycarbonyl beta-ala-try-met-phe-NIIg, Fox
Chemical Co.) was used as a stimulant of gastric secretion in both
the rat and the dog studies.

Pentagastrin was infused subcutaneously

in rats at a dose of 0.5 ug/kg/min and was delivered at a rate of 1.08
ml/hr.

In the dog, 0.5 ug/kg/min of pentagastrin was infused intra

venously at a rate of 2.5 ml/hr.

The original compound was a dry

chemical which was put into solution with a physiological saline so
lution.

Stock solutions were prepared and kept frozen until the day

of experimentation when the appropriate dilutions were made.

Physio

logical saline (0.9$) was used as the control agent against which the
effects of pentagastrin could be compared.
Nicotine sulfate (40$ commercial, Sigma Chemical Corp.) was
first prepared as an aqueous stock solution.

Following the calcula

tion of the required dose (ug/kg) the necessary dilutions were made
with normal saline.

Nicotine sulfate was infused subcutaneously in

the rats at a rate of 2.16 ml/hr.
throughout the rat experiments.

A dose of 100 ug/kg/hr was used
A dose of 150 ug/kg/hr was infused

intravenously in the dog experiments (2.5 ml/hr).
Purified natural secretin (GUI Laboratory, Karolinska Institutet,
Stockholm, Sweden) was prepared in normal saline and was also infused
subcutaneously in rats at a rate of 2.16 ml/lir.

Doses of 30-60 u/kg/hr
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were employed in the rat studies.

In the dog studies, partially

purified natural secretin (Boots Pure Drug Co., Nottingham, England)
was also prepared in normal saline and was infused at a constant rate
of 2.5 ml/hr.

A dose of 1.5 U/kg/hr was employed in these experiments.

In this investigation different secretin preparations (i.e. Boots
and Gill) were used in the rat and dog studies.

Tumpson and Johnson

(1969) have shown that in fistula rats, a single intravenous injec
tion of GUI secretin at a dose of 75 U/kg maximally inhibits pentagastrin-stimulated gastric secretion.

However, in the dog, Johnson

and Grossman (1968) have observed near maximal (90 percent) inhibi
tion of gastrin-stimulated gastric secretion, following an intraven
ous administration of only k u/kg/hr of GUI secretin.

Therefore, it

is apparent from the results obtained by these investigators that the
rat is more resistent to the inhibitory effect of secretin on gastric
acid secretion.

The GUI secretin, being more pure, is nine times

more potent than the partially purified Boots secretin preparation
(i.e. 1 U of GUI secretin is equivalent to 9 U of Boots secretin;
Grossman,1969)o

Since large quantities of Boots secretin would be

necessary to inhibit gastric secretion in rats, we chose in our rat
studies to use the more potent GUI secretin.

Preparation of Rats

Female Upjohn rats (derived from the Sprague-Dawley strain) with
a body weight of 200-210 grams were selected for the preparation of a
chronic gastric fistula one month prior to experimental use (the
method was that of Komarov and Boyd, 1962).

Following an overnight
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fast, the animals were anesthetized with a single intraperitoneal
injection of 0.6 ml of a 2 percent sodium brevital solution (sodium
methohexital, Lily and Co.).

A stainless steel cannula was implanted

in the forestomach which is the non-glandular portion of the rat
stomach (Robert, 1971).
During the one month post-operative period, all animals were
placed in stainless steel feeding cages fitted with a narrow mesh
screen in order to minimize possible damage to the cannula.

Dur

ing this time, all animals had free access to Upjohn laboratory chow
and tap water.

Preparation of the Dog

One male mongrel dog was surgically prepared with a denervated
fundic pouch (Heidenhain) and a gastric fistula.
studies were conducted four months after surgery.

Gastric secretory
The dog, weighing

twenty-six kilograms, was fed one can of Alpo daily and had free ac
cess to Purina laboratory chow (Purina-Ralston Co.).

The animal was

also given 1.5 litre of 0.9$ sodium chloride two times daily to re
place the daily fluid and electrolyte loss through the fundic pouch
cannula.

Infusion of Rats

The chronic fistula animals were used one month following
implantation at which time their body weight averaged 250 grams.

All

animals were fasted for twenty-four hours prior to the start of each
experiment and at least one week was allowed between successive
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experiments to allow complete recovery from the effects of fasting
and fluid loss.

Two hours before the start of each experiment, all

animals were given a single subcutaneous 10 ml injection of saline
(Robert, 1972).

Robert lias shown that this saline injection re

stores body fluids which have been lost through self-imposed dehydra
tion which occurs during the fasting of rats.

This saline ad

ministration restores body fluids and results in increased gastric
secretion.
The average fasted body weight was used as the basis for calcu
lating the doses of the agents that were administered.

The prepared

solutions were then put in separate 12 ml syringes which were connect
ed by means of 21 gauge clear Tygon tubing (Transflex, Minnesota
Manufacturing Co.) to continuous-flow variable speed infusion ma
chines designed by the Upjohn Company.

After the solutions began to

flow from the tubings, the needle (21 gauge) attached to the other end
of the tubing, was introduced subcutaneously in the dorsal region and
was secured to the skin with a surgical wound clip.
placed subcutaneously as far apart as possible.

Two needles were

The needle placed in

the anterior dorsal region was used for the continuous infusion of
either saline or pentagastrin at a rate of 1.08 ml/hr.

The other

needle was placed posteriorally and was attched to a three way
juncture to allow the infusion of a combination of saline, nicotine
or secretin through a single needle.

This procedure allowed a sep

arate infusion of nicotine and secretin.
istered at a rate of 2.16 ml/hr.

These substances were admin

Following the placement of the nee

dles, the plugs of the cannulas were removed to allow the drainage
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and collection of gastric juice into 12 ml graduated centrifuge
tubes.
During tlie infusion, the animals were placed in individual
stainless steel cylindrical cages with flat bottoms and perforations
to allow adequate ventilation.

These cages permitted limited movement

hut prevented the animals from bending and chewing the tubing.
and water were witheld throughout the entire infusion period.

Food
For

each experiment the infusion and collection lasted five hours during
which time the gastric juice was collected via the cannulas.

Infusion of the Dog

The dog was fasted for eighteen hours before each experimental
run.

The fasted body weight was used as the basis for calculating the

appropriate dosage.

Studies were conducted two times per week with

at least two days between successive experiments.
During each experiment the animal was harnessed in a wooden frame
which restricted their movements and allowed complete drainage of
gastric juice.

For each experiment, pentagastrin, secretin and

nicotine sulfate were placed in separate 20 ml syringes.

The syringes

were connected by means of 21 gauge Tygon tubing to the infusion ma
chine.

At the start of each experiment a catheter (Bard Inc.) was

inserted into a femoral vein.

The catheter was connected to Tygon tub

ing equipped with a three way juncture to allow the separate infusion
of combinations of pentagastrin, secretin and nicotine sulfate.

Fol

lowing the start of the infusion the dog remained on the stand for
approximately six hours during which twenty-three successive fifteen
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19
minute collections of gastric juice were made from the Heidenhain
pouch.

The gastric fistula also remained opened to allow drainage

of the gastric juice from the main stomach.

Experimental Procedure in Hats

Initially, preliminary studies were conducted to establish the
effect of pentagastrin (0.5 ug/kg/min) on gastric secretion and the
effect of various doses of secretin (l0 - 6 0 ll/kg/hr) on pentagastrinstimulated gastric secretion.
During the experiments in which the effects of nicotine sulfate
(100 ug/kg/hr) and secretin (40 U/kg/hr)

011

gastric secretion were stud

ied, the groups consisted of pentagastrin + saline (Group i), penta
gastrin + nicotine (Group II), pentagastrin + secretin (Group III)
and pentagastrin + secretin + nicotine (Group IV).

Pentagastrin

(0.5 ug/kg/min) was infused at the start of each experiment to all
experimental animals and was continued throughout the entire five
hour period at a rate of 1.08 ml/hr.

Maximal gastric secretory re

sponse to this dose of pentagastrin was obtained after the first hour
of infusion.

At the end of this hour, the infusion of nicotine sul

fate was started in Groups II and IV and was continued for the re
maining four hours.

At the end of the second hour of infusion, sec

retin was infused along with pentagastrin in Group III and with penta
gastrin + nicotine sulfate in Group IV for the remaining three hours.
Saline was infused in Group I and at various hours in the other groups
to insure the infusion of a constant total fluid volume in all an
imals.

Figure .1 illustrates these groups and the intervals of infusion
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in each for these experiments.
Results are presented as mean values from 13-19 rats.

Signif

icance of the difference in gastric juice volume, acid output, pep
sin concentration and pepsin output in response to secretin or nic
otine + secretin between control (Group i) and experimentals
(Groups II-IV) was determined by the Dunnett Multiple Comparison
Procedure.

Experimental Procedure in the Dog

At the start of each experiment, pentagastrin (0.3 ug/kg/min)
was infused (2.5 ml/hr) through a catheter inserted into a femoral
vein.

After the gastric secretory response elicited by pentagastrin

remained stable for one hour, secretin (l.5 U/kg/hr) was added to the
intravenous infusion for one hour.

Following the removal of secretin

and the reestablishment of a secretory plateau for one hour, nico
tine sulfate was added to the infusion at a dose of 150 ug/kg/hr.
After one hour of nicotine infusion, secretin was again added to the
infusion along with nicotine.

This second administration of secretin

lasted one hour and fifteen minutes (i.e. five fifteen-minute col
lections).

Pentagastrin, nicotine sulfate and secretin were all infus

ed by means of separate syringes.

Figure 2 illustrates the general ex

perimental procedure for these experiments with nicotine and secretin.
To insure that the first secretin infusion (one hour) had no ef
fect on the results obtained when nicotine and secretin were infused
together, four additional control studies were performed during which
secretin alone was added to the intravenous infusion of pentagastrin
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at two intervals.

The first infusion of secretin lasted one hour

(i.e. four fifteen-minute collections) and corresponded to the same
time intervals in the experimental studies.

The second administra

tion of secretin remained for one hour and fifteen minutes and gastric
juice was also collected at corresponding time intervals.

In this

investigation these experiments were called secretin controls (Fig.
2).

In these secretin control studies saline was added to the infusion

in place of nicotine.
Three pentagastrin control experiments were also performed in
which pentagastrin was infused throughout the entire six hour infusion
period (Fig. 2).

In these control tests saline was infused in place

cf secretin and nicotine sulfate.
Results from these studies are presented as mean values from
at least three replicate experiments of each condition.

Significance

of the difference in gastric juice volume, acid concentration, acid
output, pepsin concentration and pepsin output in response to secretin
and nicotine + secretin was determined by the student t test.

Gastric Juice Collection and Analysis

Five hourly collections of gastric juice were made during each rat
experiment and twenty-three successive fifteen minute collections were
made during each dog experiment.

Volume, acid and pepsin determin

ations were made for each collection.

Gastric juice volume collected

from the rats was read to the nearest 0.1 ml whereas that of the dog
was made to the nearest 0.5 ml.

The acidity was determined by

titrating to pH 7 (glass electrode) with an Autoburette Titrator
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(Copenhagen Radiometer, London Co.) with 0.1 N NaOH.

Acid con

centration is expressed as raEq/L and acid output as either mEq/hr
(rat) or mEq/15 min (dog).

Pepsin concentration was determined hy

the hemoglobin method (Autoanalyzer, Technicon Corp.) and is ex
pressed as uEq tyrosine/ml.

Pepsin output (which is the product of

volume times pepsin concentration) is expressed as uEq tyrosine/hr
for the rat studies and as uEq/l5 min for the studies in the dog.
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Figure 1.

Periods of infusion of pentagastrin (0.5 ug/kg/min),
nicotine sulfate (100 ug/kg/hr) and secretin (40 U/
kg/lir) in Groups I-IV (13-19 rats). Collections of
gastric juice were made at each hourly interval.
Group I = pentagastrin + saline; Group II = penta
gastrin + nicotine; Group III = pentagastrin + sec
retin; Group IV = pentagastrin + nicotine + secretin.
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Figure 2.

Periods of infusion of pentagastrin (0.3 ug/kg/min),
nicotine sulfate (150 ug/kg/hr) and secretin (1.5 U/
kg/lir) in the dog experiments. Collections of gastric
juice were made at fifteen minute intervals.
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RESULTS

Studies in the Rat

The increase in gastric secretion in thirteen chronic fistula
rats in response to pentagastrin administration (0 .5 ug/kg/min) is
shown in Figure 3.
pentagastrin.

These results confirm the secretogogue effect of

Table 1 shows that volume, acid output and pepsin output

were significantly increased (P<.Ol) from the non-stixmilated controls
receiving only saline.

It was necessary to combine the first two and

the last three hourly collections in order to obtain enough gastric
juice to make acid and pepsin determinations for the saline controls.
Similar results concerning the effect of pentagastrin on gastric sec
retion in fistula rats have been reported by other investigators
(Adashek and Grossman, 1962; Barrett, 1966; Lee and Thompson, 1968
and 1969).
The effect of various doses of secretin (50, 40 and 60 U/kg/hr)
on pentagastrin-stimulated gastric secretion was also studied.

Figure

4 shows a dose dependent inhibition of the volume of gastric juice
collected at hourly intervals.

Maximal inhibition was attained two

hours after the start of secretin infusion.

The results in Table 2

also indicate a dose related inhibition of both volume and acid out
put.

All of the doses of secretin tested produced a significant

inhibition (P<.0l) of the volume and acid output.

A dose of 40 U/kg/

hr was chosen for use in the subsequent studies with nicotine.

This

dose of secretin decreased volume and acid output by approximately 60
27
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percent (Table 2).

Pepsin concentration was significantly increased

(P<.0l) at each dose of secretin.

Pepsin output was significantly

higher (P<.05) than control values at a dose of 3d U/kg/hr as com
pared to the other doses (40 and 60 u/kg/hr) which remained close to
control values.
Table 3 shows the effect of an infusion of nicotine sulfate
(100 ug/kg/lir- Group II), secretin (40 U/kg/hr- Group III) and nic
otine + secretin (Group IV) on volume, acid output, pepsin concentra
tion and pepsin output.

At each hourly interval following the in

fusion of nicotine sulfate (Group II), no significant difference from
the pentagastrin controls was observed in any of the parameters studied.
Maximal inhibition of pentagastrin-stimulated gastric secretion was ob
served two hours after the addition of secretin to the infusion
(Group III).

Volume and acid output were significantly reduced (p<.0l)

from the controls (Fig, 3 and 6) and were inhibited approximately 65
percent and 59 percent respectively during the final two hours of sec
retin infusion.

Pepsin concentration was significantly higher (P<»0l)

during each hour of secretin infusion (Fig. 7) whereas total pepsin
output remained unchanged (Fig. 8).

The combination of nicotine +

secretin (Group IV) produced no .'gnificant change from Group III
(i.e. the infusion of secretin alone).

Again, maximal inhibition of

pentagastrin-stimulated acid secretion was observed two hours after the
addition of secretin to the infusion (Fig. 5 and 6).

Volume was

inhibited 6l percent and acid output 47 percent and both were sig
nificantly lower (P<.01) than that of the control group.

Pepsin

concentration was significantly higher (P<.0l) during the last two
hours of secretin infusion (Fig. 7)»

Pepsin output was significantly
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increased (P<.05) following the second hour of the nicotine + secre
tin infusion hut returned to control values during the last hour of
infusion (Fig. 8).

Studies in the Dog

As described previously, the secretin + n i c o t i n e e x p e r i m e n t s
consisted of two administrations of secretin to a dog stimulated
with pentagastrin.

Secretin was first infused alone for one hour and

was later infused with nicotine.

The first intravenous infusion of

secretin (l.5 U/kg/hr) significantly decreased (P<.Ol) both the vol
ume and acid output of pentagastrin-stimulated gastric secretion
(Fig. 9 and 10).

Maximal inhibition of acid secretion at this dose

was observed thirty minutes after the start of secretin infusion and
lasted throughout the remaining period of infusion.

Upon removal

of secretin from the infusion, gastric secretion gradually rose and
reached normal values within thirty minutes.

The subsequent infusion

of nicotine sulfate (150 ug/kg/hr) produced no effect on gastric acid
secretion.

Figures 9 and 10 indicate that the second addition of secre

tin (in the presence of nicotine) failed to produce a significant de
crease in either gastric juice volume or acid output, although both
of these parameters decreased slightly.

During the periods of max

imal inhibition, secretin alone caused a significant decrease (P<.0l)
in acid concentration, whereas secretin + nicotine did not (Table 4).
Figure 12 shows that during the periods of maximal inhibition (i.e.
thirty minutes after the start of secretin) the volume of gastric juice
was decreased by 53 percent from the pentagastrin controls during the
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first administration of secretin and was decreased by only 28 per
cent when secretin was added to the infusion of nicotine.

Acid out

put was decreased by 56 percent during the infusion of secretin and
27 percent during the secretin + nicotine infusion (Fig. 13).
The effect of secretin and secretin + nicotine on pepsin con
centration and pepsin output is shown in Figures 14 and 15.
results on pepsin concentration were confusing.

The

Pepsin concentra

tion did not change during the infusion of secretin but when secretin
was added to the infusion with nicotine, pepsin concentration ap
peared to gradually increase (Fig. 14).

The first infusion of secre

tin alone produced a significant decrease (P<.05) in pepsin output
during these experimental runs.

However, the second addition of secre

tin to the infusion with nicotine did not produce a significant de
crease (Fig. 15).

Figure 16 shows a 55 percent decrease in pepsin

output was produced by secretin whereas only a 7 percent decrease was
produced by the nicotine + secretin infusion.
In the secretin control experiments, secretin was added to the
infusion of pentagastrin at two intervals.

Secretin infusion pro

duced a significant decrease (P<.05 and P<.0l) of volume and acid
output during both the first and second administrations (Fig. 9 and
10).

Acid concentration was also significantly decreased (Table 4).

During the periods of maximal inhibition, secretin produced a 52 per
cent decrease in volume during the first interval of infusion and a
49 percent decrease during the second administration (Fig. 12).

Fig

ure 13 shows that acid output was decreased 53 percent and 51 percent
during the first and second administrations respectively.
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Figures 14 and 15 show the results of these secretin control
experiments on pepsin secretion.

The first infusion of secretin

showed no effect on pepsin concentration.

It is difficult to make

any correlation concerning the second period of secretin infusion
since a sharp decrease in pepsin concentration resulted thirty min
utes after secretin was added to the infusion (Fig. .14).

This de

crease was then followed by a gradual increase in pepsin concentra
tion.

Pepsin output was decreased 50 percent and 59 percent re

spectively (Fig. 16).
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Figure 3»

Effect of the infusion of pentagastrin (0.5 ug/kg/min)
on the volume of gastric juice collected at hourly in
tervals. Each point represent the mean of 13 rats in
the pentagastrin group and 12 rats in the saline con
trol group (nonstimulated). Significance of the dif
ference from the saline controls is expressed as **
when P<.01.
Horizontal bars above and below each hour indicate lim
its of the standard error of the mean for each point.

Table 1.

Comparison of volume (ml/2 or 3 hr), acid output (mEq/
2 or 3 hr) and pepsin output (uEq tyrosine/2 or 3 hr; of
nonstimulated fistula rats receiving saline with those
infused with pentagastrin (0.5 ug/kg/min). Collections
of gastric juice from the first two and last three hours
of infusion were combined. Significance of the differ
ence is expressed as ** when P<.01.
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Figure 4.

Table 2.

Effect of the infusion of various doses of secretin
(30, 40 and 60 U/kg/hr) on the volume of gastric juice
collected at hourly intervals in fistula rats stimu
lated with pentagastrin. Each point represents the mean
values for gastric juice volume from 10-15 animals in
each group. Significance of the difference from the
pentagastrin controls is expressed as * when P<.05 and
as ** when P<.01.

Effect of the infusion of various doses of secretin
(30, 40 and 60 U/kg/hr) on volume, acid output, pep
sin concentration and pepsin output during the last two
hours of infusion (i.e. 4 + 5 hours combined). The
percent change from the pentagastrin control group is
also indicated. Significant differences from the penta
gastrin controls are expressed as * when P<.05 and as
** when P<.01.
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Table 3.

Summary of the effect of an infusion of nicotine sul
fate (100 ug/kg/hr), secretin (40 U/kg/lir) and nicotine
+ secretin on pentagastrin-stimulated gastric secretion
in 13-19 fistula rats. Volume, acid output, pepsin con
centration and pepsin output from each hourly interval
are shown0 Significant differences are expressed as
* (P<.05) and ** (P<.0l) when treated groups (II-IV)
were compared against the pentagastrin controls (i).
Group I = pentagastrin + saline; Group II = pentagastrin
+ nicotine; Group III = pentagastrin + secretin; Group
IV = pentagastrin + nicotine + secretin.
Note:

Volume, acid output,pepsin concentration and pep
sin output of Group IV showed no significant dif
ference when compared to Group III.
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I

II

III

IV

19

13

17

15

2.17

2.54

2.42

2.43

Acid output (mEq/hr)

.28

.32

.32

.31

Pepsin concentration
(uEq tyrosine/ml)
Pepsin output
(uEq tyrosine/hr)

2.58

2.39

2.42

2.05

5.50

5.57

5.85

4.81

Volume

1.96

2 .3 0

2.41

2.00

.28

.31

.36

.27

Pepsin concentration

2.04

1.92

2.21

1.82

Pepsin output

4.02

4.40

5.51

3.54

Volume

1.75

1.88

1.48

1.14 *

.25

.29

.22

Pepsin concentration

2 .0 9

2 .0 6

3.04 **

2.64

Pepsin output

3.73

3.87

5.29

3.90

Volume

1.69

1.63

.74 **

.85 **

.24

.26

.12 **

.14 **

Pepsin concentration

2.19

2.11

4.84 **

4.59 **

Pepsin output

3.65

3.97

4.57

5.32 *

Volume

1.63

1.61

.85 **

.90 **

.25

.27

.15 **

Pepsin concentration

2.23

2.19

4.78 **

.15 **
4.11 **

Pepsin output

4.08

3.94

4.61

5.40

Group
No. of Animals
Hour
Volume (ml/hr)
1

Acid output
2

Acid output
3

Acid output
4

Acid output
5

.17
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Figure 5»

Effect of nicotine sulfate (100 ug/kg/hr- Group II),
secretin (;±0 U/kg/hr- Group III) and nicotine + sec
retin (Group IV) on tlie volume of gastric secretion
from rats stimulated with pentagastrin (0.5 ug/kg/min).
Significant differences from the control (Group i) are
expressed as * when P<.05 and ** when P<.()1.
Horizontal bars above and below each hour indicate the
limits of the standard error of the mean for each point.
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Figure 6.

Effect of nicotine sulfate (100 ug/kg/hr- Group II),
secretin (40 U/kg/hr- Group III) and nicotine + sec
retin (Group IV) on acid output from fistula rats stim
ulated with pentagastrin (0.5 ug/kg/min). Significant
differences from the control (Group i) are expressed as
* when P <.05 and ** when P< .01,
Horizontal bars above and belowr each hour indicate the
limits of the standard error of the mean for each point.
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Figure 7»

Effect of nicotine sulfate (100 ug/kg/hr- Group II),
secretin (40 U/kg/hr- Group III) and nicotine + sec
retin (Group IV) on pepsin concentration from fistula
rats stimulated with pentagastrin (0.5 ug/kg/min). Sig
nificant differences from the control (Group i) are ex
pressed as * when P<.05 and ** when P<.01.
Horizontal bars above and below each hour indicate the
limits of the standard error of the mean for each point.
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Figure 8.

Effect of nicotine sulfate (100 ug/kg/hr- Group II),
secretin (40 u/kg/hr- Group III) and nicotine + sec
retin (Group IV) on pepsin output. Significant dif
ferences from the control (Group i) are expressed as
* when P<.05 and ** when P<»01.
Horizontal bars above and below each hour indicate the
limits of the standard error of the mean for each point.
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Figure 9.

Results obtained from the secretin control and secretin +
nicotine experiemnts on. the volume of gastric juice collect
ed from the Heidenhain pouch of a dog stimulated with penta—
gastrin. Collections of gastric juice were made at 15minute intervals. Each point represents the mean of three
pentagastrin controls, four secretin controls and six sec
retin + nicotine experiments.
Significant differences from the pentagastrin controls are
expressed as * ithen P<.05 and ** when P<.01.
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Figure 10.

Results obtained from the secretin control and secre
tin + nicotine experiments on acid output of gastric
juice collected from the Heidenhain pouch of a dog stim
ulated with pentagastrin. Collections were made at 15minute intervals. Each point represents the mean of three
pentagastrin controls, four secretin controls and six
secretin + nicotine experiments.
Significant differences from the pentagastrin controls are
expressed as * when P<.05 and ** when P<.01.
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Table k ,

Percent decrease in acid concentration from the penta
gastrin controls during the periods of maximal inhibition
from the secretin control and secretin + nicotine exper
iments in the dog. Each value is the mean of the last three
15-minute collections during the first administration of
secretin and of the last four 15-minute collections dur
ing the second administration.
Significant differences from the pentagastrin controls are
expressed as * when P<.05 and as ** when Pc.Ol.
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Figure 12.

Percent change from the pentagastrin controls in the vol
ume of gastric juice collected during the periods of max
imal inhibition from the secretin control and secretin +
nicotine experiments. Each bar represents the mean of the
last three 15-minute collections during the first admin
istration of secretin and from the last four 15-minute
collections during the second administration of secretin
alone (secretin control) or secretin in the presence of
nicotine.
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Figure 13.

Percent change from the pentagastrin controls in acid out
put during the periods of maximal inhibition from the sec
retin control and secretin + nicotine experiments. Each
bar represents the mean of the last three 15-minute col
lections during the first administration of secretin
alone (secretin control) or secretin in the presence of
nicotine.
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Figure 14.

Results obtained from the secretin control and secretin +
nicotine experiments on pepsin concentration of gastric
juice collected from the Heidenhain pouch of a dog stimu
lated with pentagastrin. Collections were made at 15minute intervals. Each point represents the mean of three
pentagastrin controls, four secretin controls and six
secretin + nicotine experiments.
Significant differences from the pentagastrin controls are
expressed as * when P<.05 and ** when P<.01.
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Figure 15•

llesults obtained from the secretin control and sec
retin + nicotine experiments on the pepsin output of
gastric juice collected from the Ileidenhain pouch of a
dog stimulated with pentagastrin. Collections were made
at 15-minute intervals. Each point represents the mean of
three pentagastrin controls, four secretin controls and six
secretin + nicotine experiments.
Significant differences from the pentagastrin controls are
expressed as * when P<.05 and * * when P<.01.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

60

7

min)

6

(iiEq Tyrosine/15
OUTPUT

3

PEPSIN

•

5

2

•

4

- •

SECRETIN

SECRETIN
1.5 U/kg/hr

NICOTINE-SO4 150 (ig/kg/hr

2

3

4

5

HOURS
•
•
•

PENTAGASTRIN CONTROL
SECRETIN CONTROL
SECRETIN + NICOTINE EXPERIMENTS

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

6

Figure 16.

Percent change from the pentagastrin controls in pep
sin output during the periods of maximal inhibition
from the secretin control and secretin + nicotine ex
periments. Each bar represents the mean of the last three
15-minute collections during the first administration of
secretin and of the last four 15—minute collections dur
ing the second administration of secretin alone (secretin
control) or secretin in the presence of nicotine.
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D IS C U S S IO N

Studies in the Hat

The results of this investigation confirmed that exogenous
secretin inhibits pentagastrin-stimulated gastric acid secretion in
chronic fistula rats.

The response obtained was dose related.

A

dose of AO u/kg/hr of secretin was used throughout the remaining stud
ies with nicotine since it was a submaximal dose which produced a
significant effect on gastric secretion.

The subcutaneous infusion

of secretin at this dose inhibited pentagastrin-stimulated gastric
juice volume by 62 percent and acid output by 6i percent.

Our re

sults are similar to those obtained by Tumpson and Johnson (1969) who
also observed that a subcutaneous injection of secretin (75 U/kg) in
hibited the gastric acid response of fistula rats stimulated with max
imal and supramaximal doses of pentagastrin.

A similar inhibition of

gastric secretion stimulated with pentagastrin was obtained by Chey
(1970).

In these studies, a synthetic secretin was used at a dose of

2 U/kg/hr which produced a" 50 percent decrease in the maximal acid re
sponse elicited by pentagastrin.

They also showed that the intra-

duodenal infusion of hydrochloric acid (i.e. release of endogenous
secretin) caused a similar degree of inhibition.

This inhibitory ef

fect of secretin was also obtained by Chey on fistula rats prepared
with innervated pouches (Pavlov).

The intravenous infusion of 37.5

U/kg/hr of secretin decreased the acid response of the innervated pouch
stimulated with gastrin by approximately 45 percent.

This observation

63
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64
agrees closely with the results obtu.. led in our study with the chronic
fistula rat which also has an innervated stomach.

At a slightly high

er dose of secretin (40 u/kg/hr), we obtained a 6l percent decrease
in acid secretion.
Secretin has also been shown to stimulate pepsin secretion in the
rat by increasing both the concentration and output of pepsin (Jo
hanns on ut aJL., 1972).

Our results showed

that doses of 30-60 U/kg/hr

increased markedly, the concentration of pepsin in fistula rats stim
ulated with pentagastrin (Table 2).

However, pepsin output was sig

nificantly higher than in the pentagastrin controls only at a dose of
30 U/kg/hr.

At doses of 40 and 60 U/kg/hr, pepsin output was lower

than at a dose of 30 U/kg/hr and was not significantly changed from the
pentagastrin controls.

Since pepsin output is the product of pepsin

concentration times volume, the lower values for pepsin output at the
higher doses of secretin (40 and 60 u/kg/hr) was due primarily to the
greater decrease in the volume of gastric juice.

Johannson et al.

(1972) have shown that the continuous infusion of secretin (37.5
U/kg/hr) at a dose which decreased gastric acid secretion by 40-45
percent, caused a significant increase in total pepsin secretion from
the response of the innervated pouch stimulated with gastrin.

In our

investigation, the infusion of 40 U/kg/hr caused a nonsignificant ef
fect, increasing pepsin output by 19 percent (Table 2).

However, this

dose inhibited gastric juice volume by 60 percent which is a greater
inhibition than that obtained by Johannson jet al.

This greater de

crease in gastric juice volume which we observed, resulted in a less
marked increase in pepsin output.
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Our results shoved that in the rat, nicotine did not alter the
effect of exogenous secretin on gastric acid secretion (volume and
acid output).

The subcutaneous infusion of secretin at a submax-

imal dose of 40 U/kg/br significantly decreased both the volume and
acid output of gastric juice.

The combination of nicotine sulfate

with secretin did not influence this inhibition produced by secretin.
Pepsin concentration was significantly higher following the infusion
of secretin.

Again, when nicotine sulfate was infused with secretin,

nicotine failed to influence the rise in pepsin concentration pro
duced by secretin.

Pepsin output was not significantly changed from

the pentagastrin controls following the infusion of either secretin
alone (Group III) or nicotine + secretin (Group IV).
The dose of nicotine employed in these studies (100 ug/kg/hr)
was used for the following reasons:

a) First, in the dog, this dose

had been shown to have no effect on gastric secretion stimulated with
pentagastrin (Konturek et al.. 1970)«

b) Second, in our studies, nic

otine sulfate infused subcutaneously in fistula rats at a dose of
100 ug/kg/lir did not affect gastric secretion stimulated with penta
gastrin (Table 5).

nigher doses of nicotine sulfate (300-600 ug/kg/hr)

were also tested but were observed to cause restlessness in the anim
als and also to inhibit gastric secretion.

A similar inhibitory ef

fect of high doses of nicotine on gastric secretion has also been
shown in the cat (Konturek et al., 1971)•

In this study by Konturek,

retching and restlessness were also observed.

In our studies, any

effect of nicotine itself on gastric secretion would be undesirable
since this would interfere with the gastric effects of secretin.
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c) Third, although nicotine at 100 ug/kg/hr showed no effect on gastric
secretion, it is a dose which has been shown to increase the inci
dence and severity of duodenal ulcers in rats produced by the contin
uous infusion of pentagastrin (Robert, 1973).

Therefore, this was a

dose which, in the rat, was absorbed in amounts sufficient enough to
produce an observable physiological response,

d) Fourth, Thompson

(1970) has also shown that the subcutaneous infusion of nicotine
(lOO ug/kg/hr) had no effect on pentagastrin-stimulated gastric secre
tion in fistula rats.

He did observe that nicotine increased pepsin

output in rats stimulated with both maximal and subniaximal doses of
pentagastrin.

The results of our investigation did not confirm this

stimulatory effect of nicotine on pepsin secretion.
The opposite results obtained in the present investigation where
by nicotine partially blocks the effect of exogenous secretin on gas
tric secretion in the dog but not in the rat, may be due to a true
difference between these two animal species.

The possibility also

exists that with the chronic fistula preparation in the rat, not all
of the acid flowing from the main stomach was collected externally,
a l l ow in g

some acid to flow over the duodenum.

Acid flowing over the

duodenum would release endogenous secretin and possibly other intes
tinal inhibitors of gastric secretion such as cholecystokinin (Wormsley and Grossman, 196b).

The exogenous administration of cholecysto

kinin extracts (CCK) has been shown to inhibit pentagastrin-stimulated
gastric acid secretion in rats (Tumpson and Johnson, 1969) prepared
with gastric fistulas.

On the other hand, the intravenous infusion

of a synthetic cholecystokinin produced no effect when given to
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chronic fistula rats stimulated with either pentagastrin or hist
amine (Chey et al.,1970).

Exogenous cholecystokinin has also been

shown to inhibit gastric secretion stimulated with gastrin or penta
gastrin in dogs (Gillespie and Grossman, 196^; Stening et al., 1969)
and in humans (Chey et al., 1970).

Endogenous cholecystokinin has

been shown to potentiate the effect of exogenous secretin on the dog
pancreas (Meyer et al., 1971)•

The possibility exists that such a

potentiation exists between CCK and secretin on the rat stomach. This
has not yet been determined.

If such a condition existed during our

investigation with the rat, unknown amounts of endogenous CCK and
secretin might have been released by acid flowing over the duodenum,
the result being an even stronger inhibition of gastric secretion
which could not be blocked by nicotine.

The observation by Grossman

et al. (1970) that nicotine blocks secretin-stimulated pancreatic
secretion but does not block pancreatic secretion stimulated by CCK
lends support to this explanation.

Studies in the Dog

Since Greenlee et al. (1957) reported that extracts containing
secretin inhibited gastric secretion of acid in dogs stimulated with
food and antral irrigation, their results have been confirmed and ex
tended by many other investigators.

Both exogenous and endogenous

secretin have been shown to inhibit gastric acid secretion in other
species including the rat (Tumpson and Johnson, 1969; Chey et al.,
1970; Johannson et al., 1972), cat (Stening et al., 1969) and man

(Konturek, 1970; Chey et al., 1970).

Our investigation has also
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confirmed the gastric secretory inhibition produced by secretin.
Continuous infusion of secretin at a dose of 1.5 U/kg/hr produced a
significant decrease in gastric juice volume and acid output in a
dog stimulated with pentagastrin.

This was the response of the de-

nervated fundic pouch (Heidenhain).
Secretin has also been shown to stimulate pepsin secretion in
experiments using rats (Johannson et al., 1972), cats (Stening et al_.,
1969), dogs (Magee and Nakajima, 1968; Stening et al., 1969) and
humans (Berstad, 1970)•

In our investigation in the dog, it was ob

served that pepsin output decreased following the administration of
secretin.

The contradictory nature of these results was difficult to

explain but was apparently a result of the large decrease in the vol
ume of gastric juice.

Stening et al.. (1969) observed that when secre

tin produced a strong inhibition of the volume of gastric secretion
using dogs stimulated with gastrin, it was not possible to obtain re
liable values for pepsin output.
creased pepsin concentration.

He did observe that secretin in

Magee and Nakajima (1969) reported an

increase in pepsin output even with a dose of secretin that caused a
significant decrease in acid output.
The results of our studies also confirmed that the continuous
infusion of nicotine alone (150 ug/kg/hr) produced no effect on the
response of the Heidenhain pouch stimulated with pentagastrin.

Kon

turek et al., (l97l) have previously shown that an intravenous in
fusion of nicotine (100 ug/kg/hr) in dogs, had no effect on one-half
maximal gastric acid secretion evoked by either histamine or penta
gastrin,

Nicotine infusion also failed to alter basal gastric acid
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output.

In this study by Konturek et al., nicotine depressed secre

tin-stimulated pancreatic and basal hepatic secretion of bicarbonate.
Our findings indicated that intravenously infused nicotine block
ed the inhibitory effect of secretin on gastric secretion stimulated
with pentagastrin.

In the secretin control experiments, the adminis

tration of secretin (1.5 U/kg/hr) produced a significant decrease in
gastric juice volume and acid output.

This dose of secretin was ap

proximately the ED5() which was the dose that inhibited gastric secre
tion by 50 percent.

When nicotine was infused along with secretin, a

nonsignificant decrease in gastric acid secretion resulted (decreased
by only 27 percent).

Our results indicated that nicotine blocked the

inhibitory effect of secretin (ED^^) on gastric secretion by onehalf.
It was important that the experiments in this investigation were
conducted in a dog with an open gastric fistula.

This allowed gas

tric juice from the main stomach to flow externally so that acid could
not enter the duodenum and release unknown amounts of endogenous sec
retin (Johnson and Grossman, 1968).
A number of other conditions concerning the effect of nicotine
on gastric secretion influenced by secretin remain to be examined.
The results of this investigation were those obtained from one dog.
Experiments of this nature should be performed in a number of addi
tional animals to account for individual variations within a species.
Also, the effect of nicotine on gastric secretion inhibited by endog
enous secretin has not been investigated.

Konturek et al. (1972)

have shown that nicotine blocked pancreatic secretion stimulated with
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both endogenous and exogenous secretin*

In this same study, Kon

turek et_ al. have concluded that nicotine was a competitive inhibitor
of secretin since the percentage of inhibition by nicotine decreased
as the dose of secretin increased.

They have shown that at a dose of

1.5 U/kg/hr (EDj_q) of secretin, nicotine blocked pancreatic secretion
stimulated with secretin by 49 percent.

Our findings show that nic

otine blocked the inhibitory effect of 1.5 U/kg/hr of secretin (ED,_q )
on gastric secretion by 47 percent.
Finally, the results from our investigation showed the gastric
response from a denervated portion of the stomach (Heidenhain pouch).
The importance of vagal innervation in the regulatory effect of acid
in the duodenum on gastric secretion has been shown (Code and Watkinson, 1955 )e

They observed that irrigation of the duodenum with exog

enous acid inhibited histamine-stimulated gastric secretion from in
nervated pouches (Pavlov) but not from denervated pouches (Heiden
hain).

The validity of this investigation has been questioned by

Wormsley and Grossman (1964) since endogenous acid from the main
stomach had been allowed to drain into the duodenum during the course
of these experiments.

In contrast to this earlier study of Code and

Watkinson, Wormsley and Grossman have found that vagal innervation
was not necessary for the inhibitory action of endogenous duodenal
acidification on gastric secretion stimulated with either histamine
or gastrin.

Possible Role of Nicotine in the Pathophysiology
of Peptic Ulcer in Smokers
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The pro-ulcer effect of nicotine on the duodenum has been shown
to exist in rats (Robert jet al., 1971; Robert, 1972), in cats (Kon
turek et al., 197l) and in dogs (Toon et^ al.. 1951)•

Nicotine has

also been suggested to be a causative agent involved in the etiology
of duodenal ulcers in man (Barnett, 1927j Monson, 1970» Smoking and
Health, 1964).

Recent work by K o n t u r e k et_ al. (l972) in dogs, has

suggested that nicotine exerts this pro-ulcer effect by decreasing
the stimulatory effect of secretin on volume and bicarbonate con
tent of pancreatic juice.

They have shown that the intravenous in

fusion of nicotine decreased pancreatic secretion of fluid and bicar
bonate into the duodenum when the pancreas had been stimulated by ex
ogenous or endogenous secretin released by the intraduodenal infusion
of acid.

Duodenal ulcer formation could be due partly to nicotine-

induced interference with the neutralizing of gastric acid within the
duodenum.

A hyperacidic milieu within the lumen of the duodenum

would damage the mucosa.
Although Robert (1972) has shown that nicotine potentiates the
effect of certain secretogogues on the rat duodenum, it appears from
our results in the rat, that this effect cannot be explained as a re
sult of the interference by nicotine on the inhibitory effect of secre
tin on gastric secretion.

However, it is plausible that nicotine

favors ulcer formation in the rat by preventing the secretion of pan
creatic juice as shown by Konturek et al. (1972) in the dog.

A sim

ilar study on pancreatic secretion has not been performed in rats.
Furthermore, a complete explanation cannot be obtained until the ef
fect of nicotine is studied on gastric secretion inhibited by
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endogenous secretin.
The results of this present investigation in the dog, lend sup
port to the mechanism proposed by Konturek for the ulcer effect of
nicotine, since nicotine also appears to block the effect of secretin
on the stomach.

In the dog, nicotine appears to create a hyperacid-

ic condition within the duodenum in two ways.

First, nicotine in

hibits secretin-stimulated pancreatic secretion, an alkaline secre
tion which would normally neutralize gastric acid within the duo
denum (Konturek et al., 1972).

Second, from the results of the pres

ent study, it also appears that nicotine blocks the inhibitory effect
of secretin on gastric secretion which results in even greater amounts
of acid flowing over the duodenum.

Although this explanation is

plausible, it must be remembered that secretin is not the only intes
tinal inhibitor of gastric secretion.

Cholecystokinin has also been

shown to inhibit pentagastrin-stimulated gastric secretion in rats
(Tumpson and Johnson, 1969), dogs (Gillespie and Grossman, 1964; Stening et al., 1969) and in humans (Chey et al.. 1970) and may be re
leased to inhibit gastric secretion along with secretin.

Futhermore,

Konturek et al. (l972) have shown that nicotine did not block pan
creatic secretion evoked by cholecystokinin whereas it did block pan
creatic secretion stimulated with secretin.

The condition may also

exist where nicotine does not block gastric secretion inhibited by
cholecystokinin.

However, Johnson and Grossman (1968) provided ev

idence that secretin is probably the only enterogastrone (i.e. an
intestinal inhibitor of gastric secretion) released by acid in the
duodenum.
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The results obtained from our investigation and from those ob
tained by Konturek et_ al. (1972) suggest a possible role of nico
tine in the pathophysiology of duodenal ulcer in smokers.

If in

man, nicotine influences the stimulatory effect of secretin on the
pancreas as well as its inhibitory effect on the stomach as it does
in the dog, nicotine may also create a hyperacidic milieu within th e
duodenum.

Excess acid in the duodenum is a condition which is known

to be ulcerogenic.
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SUMMARY

Nicotine, a component of cigarette smoke, has been shown in
laboratory animals, to potentiate the ulcerogenic effect of certain
secretogogues for the duodenum.

Also, smokers have been shown to

have a higher incidence of peptic (duodenal) ulcer than people who
do not smoke.

Although evidence has been provided for this pro-ulcer

effect of nicotine, few studies have been performed to explain its
mechanism.
Secretin, a hormone released from the duodenum, acts to prevent
a hyperacidic condition within the duodenum (i.e. a condition which
is ulcerogenic) by stimulating the secretion of alkaline pancreatic
juice and by inhibiting gastric secretion of acid.
Recent evidence suggests that in dogs, nicotine may act to create
a hyperacidic milieu in the duodenum by blocking the stimulatory ef
fect of secretin on pancreatic secretion.
In studying the effect of nicotine on the gastric-inhibitory ef
fect of secretin, the inhibition by secretin of pentagastrin-stimulated gastric secretion was first confirmed.

The dose of secretin

infused subcutaneously in gastric fistula rats decreased gastric se
cretion by 59 percent whereas the dose infused intravenously in a dog
decreased gastric secretion by 56 percent.

When nicotine was infused

with secretin, gastric secretion of acid was depressed approximately
50 percent in the fistula rat.

In the dog, the combination of secret

in with nicotine decreased gastric acid secretion by only 27 percent.
Nicotine infused alone did not influence gastric secretion in either
74
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species.
Two conclusions can be made from these findings.

First, in

the rat, nicotine does not influence the inhibition of gastric acid
secretion produced by secretin.

Secondly, in the dog, nicotine par

tially blocks the inhibitory effect of secretin on gastric acid se
cretion.
If the response of the human stomach to nicotine is similar to
that observed in the dog, nicotine may act to create a hyperacidic
condition within the duodenum of smokers in two ways.

First, nico

tine may also block the stimulatory action of secretin on the produc
tion of alkaline pancreatic juice.

In addition, nicotine may also

block the inhibitory effect of secretin on gastric secretion of acid.
However, the results obtained in the rat studies are contrary to this
interpretation and emphasize that it is conjectural at this time.
Whether nicotine would alter the stimulatory effect of secretin on
the rat pancreas remains to be examined.
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